|
|
|
Insider
Information: |
Capello Jeffrey D |
Relationship: |
Director |
City: |
Wellesley |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
108,080 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$10,636,638 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
108,080 |
|
|
Total
Value |
$10,636,638 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Perkinelmer Inc |
PKI |
SVP & CFO |
2008-01-29 |
91,428 |
2004-01-27 |
0 |
Premium* |
|
Boston Scientific Corp |
BSX |
EVP & Chief Financial ... |
2013-11-27 |
447 |
2009-06-16 |
0 |
Premium* |
|
Tempest Therapeutics, Inc |
TPST |
Director |
2013-03-18 |
11,111 |
2013-03-18 |
0 |
Premium* |
|
Biogen Idec Inc |
BIIB |
EVP & Chief Financial ... |
2020-02-12 |
3,118 |
2019-01-02 |
0 |
Premium* |
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2024-06-13 |
1,976 |
2024-06-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
69 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2013-06-16 |
4 |
D |
$9.51 |
$59,980 |
D/D |
(6,307) |
197,447 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2011-02-16 |
4 |
D |
$7.10 |
$46,441 |
D/D |
(6,541) |
83,000 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2013-02-16 |
4 |
D |
$7.54 |
$50,201 |
D/D |
(6,658) |
157,347 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2012-02-16 |
4 |
D |
$5.97 |
$40,118 |
D/D |
(6,720) |
114,087 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2013-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,235 |
191,448 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2012-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,236 |
136,041 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2012-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,064 |
122,151 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2011-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,065 |
91,065 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2013-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,065 |
165,412 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP, Chief Accounting Officer |
|
2009-06-16 |
4 |
D |
$9.01 |
$83,892 |
D/D |
(9,311) |
20,014 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Chief Accounting Officer |
|
2004-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
20,000 |
|
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,474 |
187,628 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,475 |
132,126 |
0 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2013-03-18 |
4 |
B |
$9.00 |
$99,999 |
D/D |
11,111 |
11,111 |
2.39 |
- |
|
PKI |
Perkinelmer Inc |
Chief Accounting Officer |
|
2004-03-03 |
4 |
AS |
$21.60 |
$270,000 |
D/D |
(12,500) |
20,000 |
|
- |
|
PKI |
Perkinelmer Inc |
Chief Accounting Officer |
|
2004-03-03 |
4 |
OE |
$8.16 |
$102,000 |
D/D |
12,500 |
32,500 |
|
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2011-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,662 |
105,221 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2013-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,665 |
203,754 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Chief Accounting Officer |
|
2004-11-03 |
4 |
OE |
$12.22 |
$203,671 |
D/D |
16,667 |
36,667 |
|
- |
|
PKI |
Perkinelmer Inc |
Chief Accounting Officer |
|
2004-11-03 |
4 |
AS |
$22.00 |
$366,674 |
D/D |
(16,667) |
20,000 |
|
- |
|
PKI |
Perkinelmer Inc |
VP Finance & CAO |
|
2005-10-31 |
4 |
OE |
$12.22 |
$203,671 |
D/D |
16,667 |
54,011 |
0 |
- |
|
PKI |
Perkinelmer Inc |
VP Finance & CAO |
|
2005-10-31 |
4 |
AS |
$22.00 |
$366,674 |
D/D |
(16,667) |
37,344 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Chief Accounting Officer |
|
2005-01-25 |
4 |
A |
$21.02 |
$364,087 |
D/D |
17,321 |
37,321 |
|
- |
|
PKI |
Perkinelmer Inc |
SVP & CFO |
|
2008-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
17,699 |
91,428 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,312 |
183,124 |
0 |
- |
|
69 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|